Gene polymorphisms within regions of complement component C1q in HIV associated preeclampsia

Sumeshree Govender1, Nihar R Nayak2, Louansha Nandlal1

  • 1Optics and Imaging Centre, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Insights

Single nucleotide polymorphisms (SNPs) in the C1q gene are not linked to preeclampsia (PE) in African ancestry women. However, the C1q rs292001 GA genotype may influence PE susceptibility, particularly with HIV infection.

Area of Science:

  • Immunogenetics
  • Reproductive Medicine
  • Infectious Diseases

Background:

  • Preeclampsia (PE) is a pregnancy complication with complex etiology.
  • The complement system, particularly C1q, plays a role in immune regulation and may be implicated in PE pathogenesis.
  • Human immunodeficiency virus (HIV) infection can alter immune responses and potentially interact with PE development.

Purpose of the Study:

  • To investigate the association between C1q gene polymorphisms (rs292001 and rs294183) and preeclampsia in women of African ancestry.
  • To explore potential interactions between these C1q gene variants, HIV infection, and preeclampsia risk.

Main Methods:

  • A case-control study involving 325 pregnant women of African ancestry.
  • Participants were categorized into normotensive and preeclamptic groups, with further stratification by HIV status (infected vs. uninfected).
  • Genotyping for C1q SNPs rs292001 and rs294183 was performed using a TaqMan® SNP Genotyping assay.

Main Results:

  • No significant differences in allelic or genotype frequencies for C1q rs292001 and rs294183 were found between preeclamptic and normotensive women.
  • No significant associations were observed between these SNPs and preeclampsia, regardless of HIV status.
  • A potential role for the heterozygous GA genotype at C1q rs292001 was suggested, with an odds ratio of 1:2 in preeclamptic women.

Conclusions:

  • C1q gene polymorphisms rs292001 and rs294183 are not directly associated with preeclampsia development in women of African ancestry.
  • The C1q rs292001 heterozygous GA genotype may confer susceptibility to preeclampsia, irrespective of HIV status.
  • This finding suggests potential dysregulation of C1q, impacting complement function and immune responses in HIV-positive women with preeclampsia.
Abstract